DE69430867D1 - Verwendung von terbinafin zur behandlung von pneumocystosis - Google Patents

Verwendung von terbinafin zur behandlung von pneumocystosis

Info

Publication number
DE69430867D1
DE69430867D1 DE69430867T DE69430867T DE69430867D1 DE 69430867 D1 DE69430867 D1 DE 69430867D1 DE 69430867 T DE69430867 T DE 69430867T DE 69430867 T DE69430867 T DE 69430867T DE 69430867 D1 DE69430867 D1 DE 69430867D1
Authority
DE
Germany
Prior art keywords
pct
terbinafin
pneumocystosis
treating
date sep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69430867T
Other languages
English (en)
Other versions
DE69430867T2 (de
Inventor
Simone Claudio De
Carlo Contini
Sonia Tzoutzoglou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actial Farmaceutica Ltda
Original Assignee
VSL Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VSL Pharma Ltd filed Critical VSL Pharma Ltd
Publication of DE69430867D1 publication Critical patent/DE69430867D1/de
Application granted granted Critical
Publication of DE69430867T2 publication Critical patent/DE69430867T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69430867T 1993-03-12 1994-03-11 Verwendung von terbinafin zur behandlung von pneumocystosis Expired - Fee Related DE69430867T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
PCT/IT1994/000023 WO1994020082A1 (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis

Publications (2)

Publication Number Publication Date
DE69430867D1 true DE69430867D1 (de) 2002-08-01
DE69430867T2 DE69430867T2 (de) 2003-01-02

Family

ID=11401596

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430867T Expired - Fee Related DE69430867T2 (de) 1993-03-12 1994-03-11 Verwendung von terbinafin zur behandlung von pneumocystosis

Country Status (12)

Country Link
US (1) US5719192A (de)
EP (1) EP0692963B1 (de)
JP (1) JPH08508012A (de)
KR (1) KR100343031B1 (de)
AT (1) ATE219667T1 (de)
CA (1) CA2157590C (de)
DE (1) DE69430867T2 (de)
DK (1) DK0692963T3 (de)
ES (1) ES2178650T3 (de)
IT (1) IT1261776B (de)
PT (1) PT692963E (de)
WO (1) WO1994020082A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003360D0 (en) 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
BRPI0418589A (pt) 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc composições farmacêuticas e métodos para tratamento por insulina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes

Also Published As

Publication number Publication date
EP0692963A1 (de) 1996-01-24
ATE219667T1 (de) 2002-07-15
DK0692963T3 (da) 2002-10-14
WO1994020082A1 (en) 1994-09-15
CA2157590C (en) 2006-01-10
PT692963E (pt) 2002-10-31
EP0692963B1 (de) 2002-06-26
CA2157590A1 (en) 1994-09-15
ES2178650T3 (es) 2003-01-01
US5719192A (en) 1998-02-17
KR100343031B1 (ko) 2002-11-07
DE69430867T2 (de) 2003-01-02
JPH08508012A (ja) 1996-08-27
ITRM930154A1 (it) 1994-09-12
IT1261776B (it) 1996-06-03
ITRM930154A0 (it) 1993-03-12
KR960700699A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE59401401D1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
ATE177646T1 (de) Protein präparate zur verhütung und behandlung van periodontitis und sonstigen bakteriellen erkrankungen der mundhöhle
DE69430867T2 (de) Verwendung von terbinafin zur behandlung von pneumocystosis
DE69400704D1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE60210804D1 (de) Verwendung von propionyl-l-carnitin oder dessen pharmakologisch akzeptabler salze zur herstellung eines medikamentes zur behandlung von la peyronie's krankheit
MD1296F1 (en) The Nicolau method of treatment of the lichen planus
UA29236A (uk) Спосіб лікування пізніх гестозів

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ACTIAL FARMACEUTICA LDA., FUNCHAL, MADEIRA, PT

8328 Change in the person/name/address of the agent

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN

8339 Ceased/non-payment of the annual fee